Dayton Therapeutics Company

We are a clinical oncology company with the ability to identify compounds for the treatment of new cancer indications with limited therapeutic options. We have identified satraplatin as having a significant effect in haemato-oncology indications and are developing it as a precision platinum for orphan lymphomas. We are scaling up the process of identifying and developing clinical compounds using proprietary oncologist know-how amplified by AI and data mining to systematically pursue high-yield candidates for cancer indications of large unmet medical need.
Technology: Artificial Intelligence, Biotechnology, Life Science, Pharmaceutical
Industry: Clinical Development
Headquarters: Steinhausen, Zug, Switzerland
Founded Date: 2020-05-01
Employees Number: 1-10

Visit Website
Register and Claim Ownership